These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27103473)

  • 1. Huntington disease: New study challenges the hypothesis of glutamate transporter dysfunction in Huntington disease.
    Malkki H
    Nat Rev Neurol; 2016 May; 12(5):251. PubMed ID: 27103473
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models.
    Parsons MP; Vanni MP; Woodard CL; Kang R; Murphy TH; Raymond LA
    Nat Commun; 2016 Apr; 7():11251. PubMed ID: 27052848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model.
    Zhang Y; He X; Meng X; Wu X; Tong H; Zhang X; Qu S
    Cell Death Dis; 2017 Feb; 8(2):e2574. PubMed ID: 28151476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters.
    Estrada-Sánchez AM; Montiel T; Segovia J; Massieu L
    Neurobiol Dis; 2009 Apr; 34(1):78-86. PubMed ID: 19168136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired PLP-dependent metabolism in brain samples from Huntington disease patients and transgenic R6/1 mice.
    Sorolla MA; Rodríguez-Colman MJ; Vall-Llaura N; Vived C; Fernández-Nogales M; Lucas JJ; Ferrer I; Cabiscol E
    Metab Brain Dis; 2016 Jun; 31(3):579-86. PubMed ID: 26666246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats.
    Chung EK; Chen LW; Chan YS; Yung KK
    J Comp Neurol; 2008 Dec; 511(4):421-37. PubMed ID: 18831527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.
    Traficante A; Riozzi B; Cannella M; Rampello L; Squitieri F; Battaglia G
    Neuroreport; 2007 Dec; 18(18):1997-2000. PubMed ID: 18007201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington's disease mice.
    McClory H; Williams D; Sapp E; Gatune LW; Wang P; DiFiglia M; Li X
    Acta Neuropathol Commun; 2014 Dec; 2():179. PubMed ID: 25526803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dearth of glutamate transporters contributes to striatal excitotoxicity.
    Brustovetsky T; Purl K; Young A; Shimizu K; Dubinsky JM
    Exp Neurol; 2004 Oct; 189(2):222-30. PubMed ID: 15380474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow.
    Gianfriddo M; Melani A; Turchi D; Giovannini MG; Pedata F
    Neurobiol Dis; 2004 Oct; 17(1):77-88. PubMed ID: 15350968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal synaptic dysfunction and altered calcium regulation in Huntington disease.
    Raymond LA
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1051-1062. PubMed ID: 27423394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of phosphodiesterase 10A, dopamine receptors D1 and D2 and dopamine transporter ligand binding in the striatum of the R6/2 and BACHD mouse models of Huntington's disease.
    Miller S; Hill Della Puppa G; Reidling J; Marcora E; Thompson LM; Treanor J
    J Huntingtons Dis; 2014; 3(4):333-41. PubMed ID: 25575954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice.
    Dau A; Gladding CM; Sepers MD; Raymond LA
    Neurobiol Dis; 2014 Feb; 62():533-42. PubMed ID: 24269729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolving pathobiological mechanisms relating to Huntington disease: gait, balance, and involuntary movements in mice with targeted ablation of striatal D1 dopamine receptor cells.
    Kim HA; Jiang L; Madsen H; Parish CL; Massalas J; Smardencas A; O'Leary C; Gantois I; O'Tuathaigh C; Waddington JL; Ehrlich ME; Lawrence AJ; Drago J
    Neurobiol Dis; 2014 Feb; 62():323-37. PubMed ID: 24135007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy.
    Tkac I; Dubinsky JM; Keene CD; Gruetter R; Low WC
    J Neurochem; 2007 Mar; 100(5):1397-406. PubMed ID: 17217418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen consumption deficit in Huntington disease mouse brain under metabolic stress.
    Lou S; Lepak VC; Eberly LE; Roth B; Cui W; Zhu XH; Öz G; Dubinsky JM
    Hum Mol Genet; 2016 Jul; 25(13):2813-2826. PubMed ID: 27193167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate-induced neuronal degeneration: studies on the role of glutamate re-uptake.
    Schwarcz R; Köhler C; Mangano RM; Neophytides AN
    Adv Biochem Psychopharmacol; 1981; 27():403-12. PubMed ID: 6449833
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible cellular mechanism accounting for the cell type-specific vulnerability in Huntington's disease.
    Centonze D; Giacomini P; Tolu M; Bernardi G; Calabresi P
    Funct Neurol; 2000; 15(4):253-8. PubMed ID: 11213528
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neurotransmitters in Huntington chorea (review)].
    Barkhatova VP; Larskiĭ EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in glutamate transporter expression in mouse forebrain areas following focal ischemia.
    Ketheeswaranathan P; Turner NA; Spary EJ; Batten TF; McColl BW; Saha S
    Brain Res; 2011 Oct; 1418():93-103. PubMed ID: 21911209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.